CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease

Madeline Lauener1, Shima AzadPour2, Sayeh Abdossamadi1

  • 1Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver.

Haematologica
|October 6, 2022
PubMed

Insights

Regulatory natural killer (NK) cells (NKreg) suppress chronic graft-versus-host disease (cGvHD) after hematopoietic stem cell transplantation (HSCT). These CD56bright NK cells, identified as perforin-negative, inhibit T-cell function without causing cell death.

Area of Science:

  • Immunology
  • Transplantation Science
  • Cellular Biology

Background:

  • Chronic graft-versus-host disease (cGvHD) is a significant complication following hematopoietic stem cell transplantation (HSCT).
  • A specific population of natural killer (NK) cells, CD56bright, has been observed to correlate with a reduced incidence of cGvHD.

Purpose of the Study:

  • To isolate and characterize regulatory NK (NKreg) cells responsible for suppressing cGvHD.
  • To elucidate the mechanisms by which NKreg cells exert their suppressive function.

Main Methods:

  • Immunophenotypic analysis of NK cell populations in pediatric HSCT patients.
  • Transcriptome analysis comparing CD56bright and CD56dim NK cells.
  • In vitro co-culture assays to assess the suppressive capacity of isolated NKreg cells on T-cell subsets.

Main Results:

  • The CD56bright NK population associated with reduced cGvHD lacks perforin and Granzyme B but expresses CD335.
  • NKreg cells overexpress Granzyme K, IL-7R, GPR183, RANK, GM-CSFR, TCF7, and IL23A.
  • Isolated CD56brightCD3-CD16-perforin- NKreg cells suppress allogeneic CD4+ T cells via a non-cytolytic, cell-contact dependent mechanism, independent of NKp44, NKp46, or GPR183.

Conclusions:

  • A distinct CD56brightCD3-CD16-perforin- NKreg cell population is identified and associated with the absence of cGvHD.
  • These NKreg cells possess unique characteristics and suppress helper T-cell function in vitro.
  • Further research into NKreg cell mechanisms could lead to therapeutic strategies for cGvHD.